Averna

genomic medicines developer

Averna Therapeutics
Averna’s platform combines in silico modeling with wet lab experimentation to engineer therapeutic gene elements, enabling the creation of redoseable and titratable treatments for genetic diseases, cancer, and autoimmune conditions.

SECTOR

Health Sciences

INVESTED

2024

STATUS

Active

HQ

Watertown, MA

FOUNDERS

Incubated by Orbimed

Subscribe to hear about Arc Ventures' updates and events.